The Future of Melanoma: What to Anticipate in 2022
The Future of Melanoma: What to Anticipate in 2022 With Anthony J. Olszanski, MD, RPh and Jeffrey M. Farma, MD, FACS, codirectors of Fox Chase Cancer Centers Melanoma and Skin Cancer Program. Drs. Farma and Olszanski will discuss: new surgical and systemic options for the treatment of patients with melanoma; the role of neoadjuvant therapy prior to surgery; how it is determined which patients are considered for neoadjuvant therapy; two case studies I believe that the path towards treating any disease is best navigated by thoroughly understanding not only the disease, but also the patient. Good communication between a physician and a patient is especially critical in the treatment of cancer. Each patient has a right to be both respected and heard. In addition, relying on a team of experts to help manage the complexities of treating cancer is essential for success. As a physician, I strive to provide personalized and scientifically sound care to each of my Anthony J. Olszanski, MD, RP
|
|